Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study finds retinitis pigmentosa mutations:

This article was originally published in Clinica

Executive Summary

Two gene mutations for the inherited eye disease retinitis pigmentosa could lead to new screening and diagnostic tests for the condition, a Canadian study has revealed. The mutations, identified by investigators at the Research Institute of the McGill University Health Centre, in Montreal, Quebec, were associated with variable, severe forms of the disease and other neurological disorders, such as hearing loss. The findings appear in the American Journal of Ophthalmology (October). Around 1.5 million people worldwide are affected by retinitis pigmentosa, which causes vision loss and which has no cure.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel